Nucleostemin expression in breast cancer is a marker of more aggressive phenotype and unfavorable patients' outcome: A STROBE-compliant article.

Medicine (Baltimore) · 2019 · PMC6831441 · PMID 30817632

Europe PMC DOI

hedged sentences

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

an obvious trendP = .09so close (0.05 < p ≤ 0.1)

Combined analyses of both cohorts revealed an obvious trend of association between NS expression and the 2 more aggressive (ER-negative) breast cancer subtypes (HER-2 and TNBC) ( P = .09) (Table 3 ).

also in 1,006 other papers

did not reach statistical significanceno p-value reported

In addition, NS was also found to be more expressed in the more advanced stages III and IV (78.04%) compared to early stages I and II (61.05%) and in situ (stage 0) (66.67%) tumors of the entire cohort, however, this trend did not reach statistical significance (Table 3 ) (Fig. 2 A).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.